683 Capital Management »

Assembly Biosciences shares owned by 683 Capital Management

Quarter-by-quarter ownership of Assembly Biosciences (ASMB) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Assembly Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Assembly Biosciences held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Assembly Biosciences by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $948k 28k 34.01

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Assembly Biosciences

Gilead Sciences
Farallon Capital Management
RA Capital Management
Commodore Capital
Henderson Group
Paradigm Biocapital Advisors
Point72 Asset Management
Vanguard Group
Blackstone Group
Parkman Healthcare Partners
Franklin Resources
BlackRock
Eversept Partners
Stempoint Capital
Geode Capital Management

View all funds holding Assembly Biosciences